A detailed history of Pier 88 Investment Partners LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 7,100 shares of TXG stock, worth $130,995. This represents 0.42% of its overall portfolio holdings.

Number of Shares
7,100
Previous 4,690 51.39%
Holding current value
$130,995
Previous $262,000 1.53%
% of portfolio
0.42%
Previous 0.41%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$36.08 - $54.3 $86,952 - $130,863
2,410 Added 51.39%
7,100 $266,000
Q4 2023

Feb 09, 2024

SELL
$34.32 - $57.55 $171,600 - $287,750
-5,000 Reduced 51.6%
4,690 $262,000
Q2 2023

Aug 07, 2023

BUY
$50.96 - $58.72 $280,280 - $322,960
5,500 Added 131.26%
9,690 $541,000
Q4 2022

Feb 08, 2023

BUY
$24.4 - $41.3 $40,992 - $69,384
1,680 Added 66.93%
4,190 $152,000
Q3 2022

Nov 14, 2022

SELL
$28.48 - $52.59 $102,243 - $188,798
-3,590 Reduced 58.85%
2,510 $71,000
Q2 2022

Aug 12, 2022

BUY
$36.95 - $82.41 $138,932 - $309,861
3,760 Added 160.68%
6,100 $276,000
Q1 2022

May 13, 2022

SELL
$55.7 - $145.79 $144,263 - $377,596
-2,590 Reduced 52.54%
2,340 $178,000
Q4 2021

Feb 14, 2022

BUY
$135.05 - $182.59 $526,695 - $712,101
3,900 Added 378.64%
4,930 $734,000
Q3 2021

Nov 12, 2021

SELL
$145.58 - $192.14 $564,122 - $744,542
-3,875 Reduced 79.0%
1,030 $150,000
Q2 2021

Aug 13, 2021

SELL
$134.22 - $202.37 $166,432 - $250,938
-1,240 Reduced 20.18%
4,905 $961,000
Q1 2021

May 14, 2021

SELL
$140.25 - $196.86 $82,747 - $116,147
-590 Reduced 8.76%
6,145 $1.11 Million
Q4 2020

Feb 12, 2021

SELL
$126.47 - $163.7 $125,837 - $162,881
-995 Reduced 12.87%
6,735 $2.83 Million
Q3 2020

Nov 16, 2020

BUY
$87.44 - $125.0 $88,751 - $126,875
1,015 Added 15.12%
7,730 $964,000
Q2 2020

Aug 14, 2020

BUY
$58.39 - $89.31 $392,088 - $599,716
6,715 New
6,715 $600,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.75B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.